この調査レポートは、世界の肥満産業を薬剤タイプ別（食欲抑制剤、配合剤、吸収不良治療薬、その他の薬剤）、年齢層別（0-18歳、19-39歳、40-59歳、60歳以上）、性別（男性、女性）に、2019年から2022年の過去期間、2023年の推計、2024年から2029年の予測期間の詳細な分析を提供しています。
この調査レポートは、各地域（南北アメリカ、ヨーロッパ、APAC、中東、アフリカ）と10カ国（アメリカ、カナダ、ブラジル、イギリス、ドイツ、フランス、イタリア、スペイン、中国、日本）の詳細な分析をカバーしています。さらに、市場規模、年間成長＆潜在能力分析、市場プレイヤーの競合調査、投資機会、需要予測などのデータも掲載しています。
2024年から2029年の予測期間中、世界の肥満市場は年平均成長率14.4％で拡大すると予測されます。人口の増加に加え、健康的な食事と身体活動の重要性に関する認識と教育が限られていることが、肥満の世界市場を牽引しています。肥満の世界市場は、2022年の252億4,000万米ドルから2029年末までに617億米ドルを創出すると予測されます。食習慣の変化、グローバル化、食品の入手可能性が、世界の肥満市場の主要な推進要因として浮上しています。
世界的な肥満の流行は、21世紀における最も差し迫った公衆衛生の課題のひとつとなっています。あらゆる年齢層と地域にわたって有病率が増加している肥満は、個人、医療制度、社会全体に重大な影響を及ぼしています。この調査研究では、世界の肥満市場の複雑さを掘り下げ、その状況を形成している促進要因、抑制要因、動向を調査しています。また、肥満の増加を抑制し、より健康的な未来を育むことを目的とした革新的な解決策と戦略についても調査しています。
食生活の変化は世界の肥満市場に大きな影響を与えています。世界中の人々が新しい食事パターンと食品の選択を取り入れるにつれ、肥満と過体重の有病率は上昇傾向にあります。肥満の多くは、高カロリー、高糖質、不健康な脂肪を含む、エネルギー密度が高く、栄養価の低い食品の摂取を伴います。これらの食品はエネルギーの不均衡を引き起こす可能性があり、消費カロリーよりも多くのカロリーを摂取し、体重増加や肥満を引き起こします。
アジア太平洋地域における食生活の変化は、肥満と過体重の蔓延に大きな影響を及ぼしており、同地域における肥満市場の拡大につながっています。都市化とグローバル化が進むにつれ、伝統的な食生活がより便利な加工食品に取って代わられることもあります。こうした変化は、栄養価の高い伝統的食品の消費を減少させ、栄養の不均衡を招きます。
目次
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Focus on Education & Awareness
2.2 Focus on Telemedicine & Digital Health Solutions
3. Global Obesity Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on the Obesity Market
3.2 Number of Deaths by Risk Factors Including Obesity, World, 2019
3.3 Prevalence of Adult Obesity
3.4 Global Percentage of Adults Facing Obesity as Biggest Health Problem, 2022
3.5 Biggest Health Problems among People Worldwide, 2022
3.6 Global Obesity Market: Dashboard
3.7 Global Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
3.8 Global Impact of COVID-19 on Obesity Market
3.9 Global Obesity Market Segmentation: By Gender
3.9.1 Global Obesity Market, By Gender Overview
3.9.2 Global Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.3 Global Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
3.10 Global Obesity Market Segmentation: By Drug Type
3.10.1 Global Obesity Market, By Drug Type Overview
3.10.2 Global Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.3 Global Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.4 Global Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.4 Global Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
3.11 Global Obesity Market Segmentation: By Age Group
3.11.1 Global Obesity Market, By Age Group Overview
3.11.2 Global Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.3 Global Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.4 Global Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.5 Global Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
4. Obesity Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Obesity Market: Historic and Forecast (2019-2029)
5.1 Americas Obesity Market: Snapshot
5.2 Americas Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Obesity Market: Key Factors
5.4 Americas Obesity Market Segmentation: By Gender
5.4.1 Americas Obesity Market, By Gender Overview
5.4.2 Americas Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Obesity Market Segmentation: By Drug Type
5.5.1 Americas Obesity Market, By Drug Type Overview
5.5.2 Americas Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Obesity Market Segmentation: By Age Group
5.6.1 Americas Obesity Market, By Age Group Overview
5.6.2 Americas Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.3 Americas Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.4 Americas Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.5 Americas Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.7 Americas Obesity Market Segmentation: By Country
5.7.1 United States Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.1.1 United States Obesity Market, By Gender
5.7.1.2 United States Obesity Market, By Drug Type
5.7.1.3 United States Obesity Market, By Age Group
5.7.2 Canada Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.2.1 Canada Obesity Market, By Gender
5.7.2.2 Canada Obesity Market, By Drug Type
5.7.2.3 Canada Obesity Market, By Age Group
5.7.3 Brazil Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.3.1 Brazil Obesity Market, By Gender
5.7.3.2 Brazil Obesity Market, By Drug Type
5.7.3.3 Brazil Obesity Market, By Age Group
5.7.4 Rest of Americas Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.4.1 Rest of Americas Obesity Market, By Gender
5.7.4.2 Rest of Americas Obesity Market, By Drug Type
5.7.4.3 Rest of Americas Obesity Market, By Age Group
6. Europe Obesity Market: Historic and Forecast (2019-2029)
6.1 Europe Obesity Market: Snapshot
6.2 Europe Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Obesity Market: Key Factors
6.4 Europe Obesity Market Segmentation: By Gender
6.4.1 Europe Obesity Market, By Gender Overview
6.4.2 Europe Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Obesity Market Segmentation: By Drug Type
6.5.1 Europe Obesity Market, By Drug Type Overview
6.5.2 Europe Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Obesity Market Segmentation: By Age Group
6.6.1 Europe Obesity Market, By Age Group Overview
6.6.2 Europe Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.3 Europe Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.4 Europe Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.5 Europe Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.7 Europe Obesity Market Segmentation: By Country
6.7.1 United Kingdom Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.1.1 United Kingdom Obesity Market, By Gender
6.7.1.2 United Kingdom Obesity Market, By Drug Type
6.7.1.3 United Kingdom Obesity Market, By Age Group
6.7.2 Germany Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.2.1 Germany Obesity Market, By Gender
6.7.2.2 Germany Obesity Market, By Drug Type
6.7.2.3 Germany Obesity Market, By Age Group
6.7.3 France Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.3.1 France Obesity Market, By Gender
6.7.3.2 France Obesity Market, By Drug Type
6.7.3.3 France Obesity Market, By Age Group
6.7.4 Italy Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.4.1 Italy Obesity Market, By Gender
6.7.4.2 Italy Obesity Market, By Drug Type
6.7.4.3 Italy Obesity Market, By Age Group
6.7.5 Spain Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.5.1 Spain Obesity Market, By Gender
6.7.5.2 Spain Obesity Market, By Drug Type
6.7.5.3 Spain Obesity Market, By Age Group
6.7.6 Rest of Europe Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.6.1 Rest of Europe Obesity Market, By Gender
6.7.6.2 Rest of Europe Obesity Market, By Drug Type
6.7.6.3 Rest of Europe Obesity Market, By Age Group
7. Asia Pacific Obesity Market: Historic and Forecast (2019-2029)
7.1 Asia Pacific Obesity Market: Snapshot
7.2 Asia Pacific Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia Pacific Obesity Market: Key Factors
7.4 Asia Pacific Obesity Market Segmentation: By Gender
7.4.1 Asia Pacific Obesity Market, By Gender Overview
7.4.2 Asia Pacific Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia Pacific Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia Pacific Obesity Market Segmentation: By Drug Type
7.5.1 Asia Pacific Obesity Market, By Drug Type Overview
7.5.2 Asia Pacific Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia Pacific Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia Pacific Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia Pacific Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia Pacific Obesity Market Segmentation: By Age Group
7.6.1 Asia Pacific Obesity Market, By Age Group Overview
7.6.2 Asia Pacific Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.3 Asia Pacific Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.4 Asia Pacific Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.5 Asia Pacific Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.7 Asia Pacific Obesity Market Segmentation: By Country
7.7.1 China Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.1.1 China Obesity Market, By Gender
7.7.1.2 China Obesity Market, By Drug Type
7.7.1.3 China Obesity Market, By Age Group
7.7.2 Japan Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.2.1 Japan Obesity Market, By Gender
7.7.2.2 Japan Obesity Market, By Drug Type
7.7.2.3 Japan Obesity Market, By Age Group
7.7.3 Rest of APAC Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.3.1 Rest of APAC Obesity Market, By Gender
7.7.3.2 Rest of APAC Obesity Market, By Drug Type
7.7.3.3 Rest of APAC Obesity Market, By Age Group
8. Middle East & Africa Obesity Market: Historic and Forecast (2019-2029)
8.1 Middle East & Africa Obesity Market: Snapshot
8.2 Middle East & Africa Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle East & Africa Obesity Market: Key Factors
8.4 Middle East & Africa Obesity Market Segmentation: By Gender
8.4.1 Middle East & Africa Obesity Market, By Gender Overview
8.4.2 Middle East & Africa Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle East & Africa Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
8.5 Middle East & Africa Obesity Market Segmentation: By Drug Type
8.5.1 Middle East & Africa Obesity Market, By Drug Type Overview
8.5.2 Middle East & Africa Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle East & Africa Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle East & Africa Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle East & Africa Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.1 Middle East & Africa Obesity Market, By Age Group Overview
8.6.2 Middle East & Africa Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.3 Middle East & Africa Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.4 Middle East & Africa Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.5 Middle East & Africa Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Obesity Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Macro-Economic Factor Assessment
10.2 Value Chain Analysis
10.3 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Obesity Market
11.4 Company Profiles
11.4.1 Novo Nordisk
11.4.2 Eli Lilly and Company
11.4.3 Altimmune
11.4.4 Amgen
11.4.5 Carmot
11.4.6 Novartis
11.4.7 Zealand Pharma
11.4.8 AstraZeneca
11.4.9 Sciwind Biosciences
11.4.10 Bristol Myers Squibb
List of Figures
Figure 1: Number of Deaths by Risk Factors including obesity, World, 2019 (in Millions)
Figure 2: Prevalence of adult Obesity(%)
Figure 3: Global Percentage of Adults Facing Obesity as Biggest Health Problem, by Country 2022
Figure 4: Global Percentage of Adults facing Biggest Health Problems in 2022
Figure 5: Global Obesity Market Size, By Value, 2019-2022 (USD Billion)
Figure 6: Global Obesity Market Size, By Value, 2024-2029 (USD Billion)
Figure 7: Global Obesity Market Share, By Gender, 2022 (%)
Figure 8: Global Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 9: Global Obesity Market Absolute Opportunity, By Male, 2019-2029 (USD Billion)
Figure 10: Global Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 11: Global Obesity Market Absolute Opportunity, By Female, 2019-2029 (USD Billion)
Figure 12: Global Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 13: Global Obesity Market Absolute Opportunity, By Appetite Suppressants, 2019-2029 (USD Billion)
Figure 14: Global Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 15: Global Obesity Market Absolute Opportunity, By Combination Drugs, 2019-2029 (USD Billion)
Figure 16: Global Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 17: Global Obesity Market Absolute Opportunity, By Malabsorption Drugs, 2019-2029 (USD Billion)
Figure 18: Global Obesity Market Size, By Other Drug Types, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 19: Global Obesity Market Absolute Opportunity, By Other Drug Types, 2019-2029 (USD Billion)
Figure 20: Global Obesity Market Size, By 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 21: Global Obesity Market Absolute Opportunity, By 0-18 Years, 2019-2029 (USD Billion)
Figure 22: Global Obesity Market Size, By 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 23: Global Obesity Market Absolute Opportunity, By 19-39 Years, 2019-2029 (USD Billion)
Figure 24: Global Obesity Market Size, By 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Global Obesity Market Absolute Opportunity, By 40-59 Years, 2019-2029 (USD Billion)
Figure 26: Global Obesity Market Size, By Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Global Obesity Market Absolute Opportunity, By Above 60 Years, 2019-2029 (USD Billion)
Figure 28: Americas Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 29: Americas Obesity Market Share, By Age Group, 2022 (%)
Figure 30: Americas Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: Americas Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 32: Americas Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 33: Americas Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 34: Americas Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 35: Americas Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 36: Americas Obesity Market, 0-18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 37: Americas Obesity Market, 19-39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 38: Americas Obesity Market, 40-59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 39: Americas Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 40: United States Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 41: United States Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 42: United States Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 43: United States Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 44: United States Obesity Market Share, By Age Group, 2022 (%)
Figure 45: Canada Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 46: Canada Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 47: Canada Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 48: Canada Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 49: Canada Obesity Market Share, By Age Group, 2022 (%)
Figure 50: Brazil Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 51: Brazil Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 52: Brazil Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 53: Brazil Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 54: Brazil Obesity Market Share, By Age Group, 2022 (%)
Figure 55: Rest of Americas Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 56: Rest of Americas Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 57: Rest of America Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 58: Rest of America Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 59: Rest of America Obesity Market Share, By Age Group, 2022 (%)
Figure 60: Europe Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 61: Europe Obesity Market Share, By Age Group, 2022 (%)
Figure 62: Europe Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 63: Europe Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 64: Europe Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 65: Europe Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 66: Europe Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 67: Europe Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 68: Europe Obesity Market, 0 - 18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 69: Europe Obesity Market, 19 - 39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 70: Europe Obesity Market, 40 - 59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 71: Europe Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 72: United Kingdom Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 73: United Kingdom Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 74: United Kingdom Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 75: United Kingdom Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 76: United Kingdom Obesity Market Share, By Age Group, 2022 (%)
Figure 77: Germany Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 78: Germany Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 79: Germany Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 80: Germany Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 81: Germany Obesity Market Share, By Age Group, 2022 (%)
Figure 82: France Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 83: France Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 84: France Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 85: France Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 86: France Obesity Market Share, By Age Group, 2022 (%)
Figure 87: Italy Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 88: Italy Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 89: Italy Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 90: Italy Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 91: Italy Obesity Market Share, By Age Group, 2022 (%)
Figure 92: Spain Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 93: Spain Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 94: Spain Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 95: Spain Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 96: Spain Obesity Market Share, By Age Group, 2022 (%)
Figure 97: Rest of Europe Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 98: Rest of Europe Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 99: Rest of Europe Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 100: Rest of Europe Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 101: Rest of Europe Obesity Market Share, By Age Group, 2022 (%)
Figure 102: Asia Pacific Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 103: Asia Pacific Obesity Market Share, By Age Group, 2022 (%)
Figure 104: Asia Pacific Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 105: Asia Pacific Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 106: Asia Pacific Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 107: Asia Pacific Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 108: Asia Pacific Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 109: Asia Pacific Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 110: Asia Pacific Obesity Market, 0 - 18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Asia Pacific Obesity Market, 19 - 39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Asia Pacific Obesity Market, 40 - 59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Asia Pacific Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: China Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 115: China Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 116: China Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 117: China Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 118: China Obesity Market Share, By Age Group, 2022 (%)
Figure 119: Japan Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 120: Japan Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 121: Japan Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 122: Japan Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 123: Japan Obesity Market Share, By Age Group, 2022 (%)
Figure 124: Rest of Asia Pacific Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 125: Rest of Asia Pacific Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 126: Rest of Asia Pacific Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 127: Rest of Asia Pacific Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 128: Rest of Asia Pacific Obesity Market Share, By Age Group, 2022 (%)
Figure 129: Middle East and Africa Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 130: Middle East and Africa Obesity Market Share, By Gender, 2022 (%)
Figure 131: Middle East and Africa Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 132: Middle East and Africa Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 133: Middle East & Africa Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 134: Middle East & Africa Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 135: Middle East & Africa Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 136: Middle East & Africa Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 137: Middle East & Africa Obesity Market, 0 - 18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 138: Middle East & Africa Obesity Market, 19 - 39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 139: Middle East & Africa Obesity Market, 40 - 59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 140: Middle East & Africa Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 141: Global Impact of Drivers and Restraints
Figure 142: Market Share of Prominent Companies in Global Obesity Market, 2022 (%)
Figure 143: Novo Nordisk Revenues, 2020-2022 (USD Million)
Figure 144: Novo Nordisk Revenues, By Geographic Segments, 2022 (%)
Figure 145: Novo Nordisk Revenues, By Business Segments, 2022 (%)
Figure 146: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
Figure 147: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
Figure 148: Eli Lilly and Company Revenues, By Business Segments, 2022 (%)
Figure 149: Altimmune Revenues, 2020-2022 (USD Million)
Figure 150: Amgen Revenues, 2020-2022 (USD Million)
Figure 151: Novartis Revenues, 2020-2022 (USD Million)
Figure 152: Novartis Revenues, By Business Segments, 2022 (%)
Figure 153: Novartis Revenues, By Business Segments, 2021 (%)
Figure 154: Zealand Pharma Revenues, 2020-2022 (USD Million)
Figure 155: Zealand Pharma Revenues, By Geographic Segments, 2022 (%)
Figure 156: Zealand Pharma Revenues, By Geographic Segments, 2021 (%)
Figure 157: AstraZeneca Revenues, 2020-2022 (USD Million)
Figure 158: AstraZeneca Revenues, By Geographic Segments, 2022 (%)
Figure 159: AstraZeneca Revenues, By Geographic Segments, 2021 (%)
Figure 160: Bristol Myers Squibb Revenues, 2020-2022 (USD Million)
Figure 161: Bristol Myers Squibb Revenues, By Business Segments, 2022 (%)
Figure 162: Bristol Myers Squibb Revenues, By Business Segments, 2021 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A3: United States Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A4: United States Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A5: United States Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A6: United States Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A7: United States Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A8: Canada Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A9: Canada Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A10: Canada Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A11: Canada Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A12: Canada Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A13: Canada Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A14: Brazil Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A15: Brazil Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A16: Brazil Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A17: Brazil Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A18: Brazil Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A19: Brazil Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A20: Rest of Americas Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A21: Rest of Americas Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A22: Rest of Americas Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A23: Rest of Americas Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A24: Rest of Americas Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A25: Rest of Americas Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A26: United Kingdom Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A27: United Kingdom Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A28: United Kingdom Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A29: United Kingdom Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A30: United Kingdom Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A31: United Kingdom Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A32: Germany Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A33: Germany Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A34: Germany Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A35: Germany Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A36: Germany Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A37: Germany Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A38: France Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A39: France Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A40: France Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A41: France Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A42: France Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A43: France Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A44: Italy Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A45: Italy Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A46: Italy Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A47: Italy Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A48: Italy Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A49: Italy Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A50: Spain Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A51: Spain Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A52: Spain Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A53: Spain Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A54: Spain Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A55: Spain Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A56: Rest of Europe Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A57: Rest of Europe Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A58: Rest of Europe Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A59: Rest of Europe Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A60: Rest of Europe Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A61: Rest of Europe Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A62: China Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A63: China Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A64: China Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A65: China Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A66: China Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A67: China Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A68: Japan Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A69: Japan Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A70: Japan Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A71: Japan Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A72: Japan Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A73: Japan Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A74: Rest of Asia Pacific Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A75: Rest of Asia Pacific Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A76: Rest of Asia Pacific Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A77: Rest of Asia Pacific Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A78: Rest of Asia Pacific Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A79: Rest of Asia Pacific Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A80: Novo Nordisk Key Financials, 2020-2022
Table A81: Eli Lilly and Company Key Financials, 2020-2022
Table A82: Altimmune Revenues, 2020-2022 (USD Million)
Table A83: Amgen Revenues, 2020-2022 (USD Million)
Table A84: Novartis Key Financials, 2020-2022
Table A85: Zealand Pharma Key Financials, 2020-2022
Table A86: AstraZeneca Key Financials, 2020-2022
Table A87: Bristol Myers Squibb Key Financials, 2020-2022
